Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003

Clicks: 401
ID: 273645
2006
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #30 of 157 articles by views in Medicine

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 157 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
An unexplained resurgence of Group A streptococci (GAS) infections has been observed since the mid-1980s in the United States and Europe, particularly among intravenous drug users (IDUs). Several risk factors have been identified. Mutations in the capsule synthesis regulator genes (csrRS) have been …
Reference Key
jm2006medicinegroup Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sierra JM;Sánchez F;Castro P;Salvadó M;de la Red G;Libois A;Almela M;March F;Español M;Sambeat MA;Romeu J;Brugal MT;de Olalla PG;Gatell JM;Vila J;García F;Colomés JLL;Caylà JA;Coll P;;
Journal Medicine
Year 2006
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/16721256
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE gel humans pubmed abstract nih national institutes of health national library of medicine adult female male adolescent middle aged Prospective Studies risk factors Retrospective Studies DNA Sequence Analysis anti-bacterial agents / therapeutic use mutation disease outbreaks population surveillance substance abuse intravenous / complications cross infection / microbiology electrophoresis cross infection / epidemiology* soft tissue infections / microbiology pulsed-field streptococcal infections / microbiology soft tissue infections / drug therapy soft tissue infections / epidemiology* cross infection / drug therapy streptococcus pyogenes / isolation & purification* streptococcal infections / epidemiology* spain / epidemiology streptococcal infections / drug therapy intravenous / epidemiology* cluster analysis beta-lactams / therapeutic use molecular epidemiology streptococcus pyogenes / genetics restriction mapping pmid:16721256 doi:10.1097/01.md.0000224707.24392.52 josep m sierra francesca sánchez pere coll streptococcus pyogenes / drug effects intravenous / microbiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.